Amneal Pharmaceuticals (AMRX) Reports In-Line Q3 EPS, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 20.21 -0.23 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.44 | 52 Week High | $0.19 | |||
| Open | $19.93 | 52 Week Low | $0.07 | |||
| Day High | $20.81 | P/E | N/A | |||
| Day Low | $19.50 | EPS | $-0.01 | |||
| Volume | 6,440,042 | |||||
